These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 105240)

  • 1. The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits.
    Cocito C; Di Giambattista M
    Mol Gen Genet; 1978 Oct; 166(1):53-9. PubMed ID: 105240
    [No Abstract]   [Full Text] [Related]  

  • 2. Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit.
    Parfait R; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1981 Jul; 654(2):236-41. PubMed ID: 6793070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the binding of virginiamycin S to Escherichia coli ribosomes.
    de Bethune MP; Nierhaus KH
    Eur J Biochem; 1978 May; 86(1):187-91. PubMed ID: 95947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence stopped flow analysis of the interaction of virginiamycin components and erythromycin with bacterial ribosomes.
    Moureau P; Engelborghs Y; Di Giambattista M; Cocito C
    J Biol Chem; 1983 Dec; 258(23):14233-8. PubMed ID: 6417137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A spectrofluorimetric study of the interaction between virginiamycin S and bacterial ribosomes.
    Parfait R; de Béthune MP; Cocito C
    Mol Gen Genet; 1978 Oct; 166(1):45-51. PubMed ID: 105239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic interactions of macrolides and synergimycins on bacterial ribosomes.
    Di Giambattista M; Vannuffel P; Sunazuka T; Jacob T; Omura S; Cocito C
    J Antimicrob Chemother; 1986 Sep; 18(3):307-15. PubMed ID: 3095298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and resistance to erythromycin in Bacillus subtilis 168: the ribosomal binding of erythromycin and chloramphenicol.
    Taubman SB; Jones NR; Young FE; Corcoran JW
    Biochim Biophys Acta; 1966 Aug; 123(2):438-40. PubMed ID: 4961167
    [No Abstract]   [Full Text] [Related]  

  • 8. Localization of virginiamycin S binding site on bacterial ribosome by fluorescence energy transfer.
    Di Giambattista M; Thielen AP; Maassen JA; Möller W; Cocito C
    Biochemistry; 1986 Jun; 25(12):3540-7. PubMed ID: 3087416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between the erythromycin and chloramphenicol binding sites on the Escherichica coli ribosome.
    Langlois R; Cantor CR; Vince R; Pestka S
    Biochemistry; 1977 May; 16(11):2349-56. PubMed ID: 324517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of erythromycin to Escherichia coli ribosomes.
    Teraoka H
    J Antibiot (Tokyo); 1971 May; 24(5):302-9. PubMed ID: 4996450
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes.
    Di Giambattista M; Engelborghs Y; Nyssen E; Cocito C
    J Biol Chem; 1987 Jun; 262(18):8591-7. PubMed ID: 3110150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of chloramphenicol-binding protein in Escherichia coli ribosomes by affinity labeling.
    Pongs O; Bald R; Erdmann VA
    Proc Natl Acad Sci U S A; 1973 Aug; 70(8):2229-33. PubMed ID: 4599619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of ions and pH on the binding of virginiamycin S to ribosomes.
    Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1983 May; 757(1):92-100. PubMed ID: 6404307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lasting damage to bacterial ribosomes by reversibly bound virginiamycin M.
    Parfait R; Cocito C
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5492-6. PubMed ID: 6776538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding to ribosomes and mode of action of chloramphenicol analogues.
    Contreras A; Barbacid M; Vazquez D
    Biochim Biophys Acta; 1974 May; 349(3):376-88. PubMed ID: 4601418
    [No Abstract]   [Full Text] [Related]  

  • 16. The in vitro and in vivo inactivation of ribosomes by virginiamycin M does not entail an alteration of 5, 16 and 23 S ribosomal RNA.
    Cocito C; Vanlinden F; Branlant C
    Biochim Biophys Acta; 1983 Mar; 739(2):158-63. PubMed ID: 6402015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance.
    Tu D; Blaha G; Moore PB; Steitz TA
    Cell; 2005 Apr; 121(2):257-70. PubMed ID: 15851032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of ribosomal particles in virginiamycin sensitive and resistant mutants of Bacillus subtilis.
    Cocito C
    Biochimie; 1973; 55(2):153-61. PubMed ID: 4198188
    [No Abstract]   [Full Text] [Related]  

  • 19. Activities of ribosomal cores deprived of proteins L7, L10, L11 and L12.
    Ballesta JP; Vazquez D
    FEBS Lett; 1974 Nov; 48(2):266-70. PubMed ID: 4373291
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of erythromycin analogues on binding of [14C]erythromycin to Escherichia coli ribosomes.
    Pestka S; Lemahieu RA
    Antimicrob Agents Chemother; 1974 Oct; 6(4):479-88. PubMed ID: 4157349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.